Jan De Witte insider trades
Open-market stock purchases and sales by Jan De Witte, Director at Resmed Inc, from SEC Form 4 filings since Nov 21, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -69%.
Open-market stock purchases and sales by Jan De Witte, Director at Resmed Inc, from SEC Form 4 filings since Nov 21, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -69%.